New MRI dye could spot dangerous artery blockages better
Diagnosis
Not yet recruiting
This Phase 3 trial tests whether a new contrast agent called gadopiclenol works as well as the standard agent (Dotarem) for MRI scans to find blocked arteries in the neck, legs, or abdomen. About 315 adults with suspected vascular disease will receive both agents in random order …
Phase: PHASE3 • Sponsor: Guerbet • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC